Related Experiment Videos
The alpha2-macroglobulin gene in AD: a population-based study and meta-analysis
M N Koster1, B Dermaut, M Cruts
1Department of Epidemiology & Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands.
Neurology
|September 12, 2000
Summary
The alpha2-macroglobulin gene (A2M) shows no genetic link to late-onset Alzheimer's disease (LOAD) in white and mixed populations. However, findings suggest a potential association in early-onset AD (EOAD) and Asian populations, warranting further research.
Area of Science:
- Genetics
- Neuroscience
- Population Health
Background:
- Conflicting reports exist on the association between the alpha2-macroglobulin gene (A2M) and late-onset Alzheimer's disease (LOAD).
- Early-onset Alzheimer's disease (EOAD) is defined as disease onset before 65 years of age.
Purpose of the Study:
- To investigate the genetic role of A2M in both EOAD and LOAD.
- To conduct a comprehensive meta-analysis of all existing studies on A2M and Alzheimer's disease.
Main Methods:
- Population-based study of 100 EOAD and 344 LOAD patients from the Netherlands.
- Analysis of A2M-I/D and A2M-Ile1000Val polymorphisms in relation to the APOE epsilon4 allele.
- Meta-analysis of published case-control data from diverse ethnic groups.
Main Results:
- No significant association between A2M polymorphisms and LOAD was found in the Dutch population.
- A notable increase in A2M-1000Val carriers was observed in EOAD patients without the APOE*4 allele.
- Meta-analysis revealed no significant differences in white and mixed populations, but a decreased frequency of A2M-D in Asian patients.
Conclusions:
- A2M is unlikely to be genetically associated with LOAD in white and mixed populations.
- The observed associations in EOAD and Asian populations require further investigation and replication.
- A2M may not hold clinical relevance for LOAD in the studied populations.